Tag: medical

In this 2025 report on the best bad credit loan providers with guaranteed approval and no credit check required, we examine how MoneyMutual stands out in a shrinking industry. As other platforms disappear or get flagged for compliance violations, MoneyMutual continues to connect borrowers with fast $500 loans, emergency cash advances, and secure same-day lending access—even for people with low or no credit scores.

WINTER GARDEN, Fla., July 18, 2025 (GLOBE NEWSWIRE) -- Smith Profits™, in association with Junior Patriots, a 501c(3) nonprofit organization, announces that its founder, Robert J. Smith, MFA, The Father of Factual Storytelling’s latest release, INFLUENCE IN ACTION™ GAINS PROVEN RESULTS AND DRIVES SALES is an International #1 Best Seller.

NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 45,292 restricted stock units of the company’s common stock to 29 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of July 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).

The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skilled professional shortage. Key players include Beckton Dickinson, Teleflex, and ICU Medical, known for expanding portfolios through strategic acquisitions and innovations. The quadrant evaluates companies based on revenue, growth strategies, and product footprint across device types and applications.